Clinical studies have shown that treatment with thymosin alpha 1 increases response to vaccination.
Cynthia W. Tuthill
Advertisement
Cynthia W. Tuthill is senior vice president and chief scientific officer at SciClone Pharmaceuticals, Inc.
Articles by Cynthia W. Tuthill
Advertisement
Latest Updated Articles
Influenza Vaccine Enhancement with Immunomodulating Peptide Thymosin Alpha 1Published: January 2nd 2010 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Applying Analytical Quality by Design Principles to Biopharma Method Development and Optimization
2
CPHI Frankfurt 2025 Highlights Global Pharma Innovation and Manufacturing Leadership
3
Why Radiopharmaceuticals Are Ideal for Treating Cancer
4
Check Your Knowledge: Patient-Centric Care Through Oral Liquid Delivery
5
